BioCentury
ARTICLE | Clinical News

AAV1-FS344: Phase I/IIa data

October 27, 2014 7:00 AM UTC

A dose-escalation Phase I/IIa trial in 6 patients with Becker muscular dystrophy showed that AAV1-FS344 given by direct bilateral intramuscular quadriceps injections improved 6MWT in 4 patients. In co...